본문으로 건너뛰기
← 뒤로

Ultra-hypofractionation for node-positive prostate cancer: pushing boundaries and redefining standards.

1/5 보강
Prostate cancer and prostatic diseases 2026 Vol.29(1) p. 90-94
Retraction 확인
출처

Le Guévelou J, Jeandin M, Angrisani A, Bosetti DG, Shelan M, Zilli T

📝 환자 설명용 한 줄

Radiotherapy is a cornerstone in the management of node-positive prostate cancer.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Le Guévelou J, Jeandin M, et al. (2026). Ultra-hypofractionation for node-positive prostate cancer: pushing boundaries and redefining standards.. Prostate cancer and prostatic diseases, 29(1), 90-94. https://doi.org/10.1038/s41391-025-00976-7
MLA Le Guévelou J, et al.. "Ultra-hypofractionation for node-positive prostate cancer: pushing boundaries and redefining standards.." Prostate cancer and prostatic diseases, vol. 29, no. 1, 2026, pp. 90-94.
PMID 40341654

Abstract

Radiotherapy is a cornerstone in the management of node-positive prostate cancer. Advances in imaging modalities and radiation therapy techniques have led to the evolution of treatment standards for this patient population. This review aims to explore the therapeutic advancements of the past decade, with a focus on the role of ultra-hypofractionated radiotherapy in node-positive prostate cancer.

MeSH Terms

Humans; Male; Prostatic Neoplasms; Lymphatic Metastasis; Radiation Dose Hypofractionation; Lymph Nodes

같은 제1저자의 인용 많은 논문 (5)